Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).

Saved in:
Bibliographic Details
Title: Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study).
Authors: Pasquau, Juan1 jpasquau@gmail.com, de Jesus, Samantha E.1 samanthaedejesus@gmail.com, Arazo, Piedad2 abibi65@gmail.com, Crusells, María J.3 pcrusells@gmail.com, Ríos, María J.4 mjriosvillegas@gmail.com, Lozano, Fernando5 fernandolozano@telefonica.net, de la Torre, Javier6 jtorrel@gmail.com, Galindo, María J.7 galindo.pepa1@gmail.com, Carmena, Jorge8 carmenajor@gmail.com, Santos, Jesús9 med000854@gmail.com, Tornero, Carlos10 tornero_car@gva.es, Verdejo, Guillermo3 guillemovil@hotmail.com, Samperiz, Gloria2 gsamperiz@gmail.com, Palacios, Zaira4 zaira.palacios.baena@hotmail.com, Hidalgo-Tenorio, Carmen1 chidalgo72@gmail.com, RIDAR Study Group (CORPORATE AUTHOR)
Source: BMC Infectious Diseases. 2/28/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 1 Diagram, 4 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712334
DOI:10.1186/s12879-019-3817-6